I have never let gender get in my way.

You have to build a culture of philanthropy. In a country like India, we need to be sensitive and caring about the poorer, more disadvantaged section of our country.

My legacy is going to be in affordable health care. I am willing to invest in developing that model and the policies around it.

Unfortunately our stock is somehow not well understood by the markets. The market compares us with generic companies. We need to look at Biocon as a bellwether stock. A stock that is differentiated, a stock that is focused on R&D, and a very-very strong balance sheet with huge value drivers at the end of it.

I have a great team who has helped me build Biocon, I was very fortunate to be able to share my vision with a group of people who really were as excited about challenges as I was.

As a traditionally risk-averse nation, India has rarely been at the forefront of innovation. Indian companies have mostly imitated others and became very good at it.

I have never let gender get in my way.